# US 2010/0168714 A1 · Therapeutic agent delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168714 A1
- Document ID: US20100168714A1
- Status: Published application
- Kind: A1
- Application number: 12/529,898
- Filed: 2008-03-06
- Published: 2010-07-01
- Earliest claimed: 2007-03-06
- Assignees: Cook Incorpated
- Inventors: Jessica L. Burke; Grant T. Hoffman; Drew P. Lyons
- Web page: https://patentgrep.com/patent/US20100168714A1

## CPC

- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M 2025/1086: {having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

This present disclosure relates to a medical device and method capable of locally administering therapeutic agents efficiently. The medical device preferably includes one balloon catheter with conduits external to the balloon and with ports in the conduits where the conduits provide adequate sealing and sufficient penetration of the body vessel wall. Moreover, the placement of the conduits and location of the ports help ensure the optimal and sufficient administration of the therapeutic agent evenly to the entire treatment site. Other embodiments of the present disclosure relate to providing means to isolate the inflation medium and the therapeutic agent during administration to the treatment site and to introduce more than one therapeutic agent simultaneously to the treatment site.

## Claims

### Claim 1

A therapeutic agent delivery system comprising:
a catheter shaft having an expandable portion being inflatable between a deflated configuration and an inflated configuration, the catheter shaft extending along a longitudinal axis from a proximal end to a distal end and including an inflation lumen in communication with the expandable portion; and
a therapeutic agent delivery conduit including a therapeutic agent delivery lumen and a therapeutic agent delivery port in communication with the therapeutic agent delivery lumen; and
the therapeutic agent delivery conduit being positioned external to the expandable portion of the catheter shaft and contacting at least a portion of an external surface of the expandable portion in the inflated configuration, the therapeutic agent delivery conduit being moveable independent of the expandable portion in the deflated configuration.

### Claim 2 (depends on 1)

The system of claim 1, wherein at least a portion of the therapeutic agent delivery conduit positioned external to the expandable portion of the catheter shaft is disposed substantially parallel to the longitudinal axis of the catheter shaft when the expandable portion is in the deflated configuration.

### Claim 3 (depends on 1)

The system of claim 1, wherein the therapeutic agent delivery conduit further comprises a plurality of therapeutic agent delivery ports facing away from the portion of the external surface of the expandable portion contacting the therapeutic agent delivery conduit.

### Claim 4 (depends on 3)

The system of claim 3, wherein the plurality of therapeutic agent delivery ports are disposed longitudinally along the therapeutic agent delivery conduit in a substantially straight line.

### Claim 5 (depends on 3)

The system of claim 3, wherein the plurality of therapeutic agent delivery ports includes a first therapeutic agent delivery port located distally to a second therapeutic agent delivery port, the first therapeutic agent delivery port having a larger cross-sectional area than the second therapeutic agent delivery port.

### Claim 6 (depends on 1)

The system of claim 1, wherein the expandable portion has a longitudinally curved external surface in the inflated configuration; and
inflation of the expandable portion from the deflated configuration to the inflated configuration bends the therapeutic agent delivery conduit from a substantially straight configuration to a substantially arcuate configuration along the longitudinally curved external surface of the expandable portion in the inflated configuration.

### Claim 7 (depends on 1)

The system of claim 1, wherein at least a portion of the therapeutic agent delivery conduit positioned external to the expandable portion of the catheter shaft is disposed substantially parallel to the longitudinal axis of the catheter shaft when the expandable portion is in the deflated configuration,
wherein the portion of the therapeutic agent delivery conduit that is disposed substantially parallel to the longitudinal axis further comprises a plurality of therapeutic agent delivery ports facing away from the portion of the external surface of the expandable portion contacting the therapeutic agent delivery conduit and disposed longitudinally along the portion of the therapeutic agent delivery conduit that is disposed substantially parallel to the longitudinal axis in a substantially straight line.

### Claim 8 (depends on 1)

The system of claim 1, wherein the therapeutic agent delivery conduit and the catheter shaft are coaxially oriented along the longitudinal axis from the proximal end of the catheter shaft to the proximal end of the expandable portion of the catheter shaft.

### Claim 9 (depends on 1)

The system of claim 1, wherein the catheter shaft has a proximal portion extending from the expandable portion to the proximal end, the proximal portion of the catheter shaft including a portion of the therapeutic agent delivery lumen proximal to, and in communication with, the therapeutic agent delivery conduit.

### Claim 10 (depends on 1)

The system of claim 1, wherein said therapeutic agent delivery conduit is a first therapeutic agent delivery conduit and said portion of the external surface of the expandable portion contacting the first therapeutic agent delivery conduit is a first portion of the external surface of the expandable portion; and
wherein the therapeutic agent delivery system further comprises a second therapeutic agent delivery conduit including a second therapeutic agent delivery lumen and a second therapeutic agent delivery port in communication with the second therapeutic agent delivery lumen;
the second therapeutic agent delivery conduit being positioned external to the expandable portion of the catheter shaft and contacting at least a second portion of the external surface of the expandable portion in the inflated configuration, the second therapeutic agent delivery conduit being moveable independent of the expandable portion in the deflated configuration and the first therapeutic agent delivery conduit; and
the second therapeutic agent delivery port facing away from the second portion of the external surface of the expandable portion contacting the second therapeutic agent delivery conduit.

### Claim 11 (depends on 10)

The system of claim 10, wherein a distal end of the first therapeutic agent delivery conduit and a distal end of the second therapeutic agent delivery conduit are joined to form a distal tip positioned distally to the expandable portion of the catheter shaft, wherein the distal tip includes an annular opening adapted for receiving a guide wire, the distal tip being moveable independent of the expandable portion in the deflated configuration.

### Claim 12 (depends on 11)

The system of claim 11, wherein the first portion of the external surface of the expandable portion and the second portion of the external surface of the expandable portion are circumferentially spaced apart by a circumferential distance measured perpendicular to the longitudinal axis, the circumferential distance being substantially equal.

### Claim 13 (depends on 11)

The system of claim 11, wherein each therapeutic agent delivery conduit comprises a plurality of therapeutic agent delivery ports disposed longitudinally along each therapeutic agent delivery conduit in a substantially straight line,
the therapeutic agent delivery ports of each therapeutic agent delivery conduit including a first therapeutic agent delivery port located distally to a second therapeutic agent delivery port, the first therapeutic agent delivery port having a larger cross-sectional area than the second therapeutic agent delivery port,
the first therapeutic agent delivery port facing away from the first portion of the external surface of the expandable portion, and the second therapeutic agent delivery port facing away from the second portion of the external surface of the expandable portion.

### Claim 14 (depends on 10)

The system of claim 10, wherein the catheter shaft has a proximal portion extending from the expandable portion to the proximal end, the proximal portion of the catheter shaft including a portion of the first therapeutic agent delivery lumen proximal to, and in communication with, the first therapeutic agent delivery conduit, the proximal portion of the catheter shaft including a portion of the second therapeutic agent delivery lumen proximal to, and in communication with, the second therapeutic agent delivery conduit.

### Claim 15

A therapeutic agent delivery device comprising:
a first therapeutic agent delivery conduit, a second therapeutic agent delivery conduit, a distal tip joining the first and second therapeutic agent delivery conduits, the distal tip including an annular opening aligned along a longitudinal axis, and a proximal base separated proximally from the distal tip by a longitudinal distance, the proximal base joining the first and second therapeutic agent delivery conduits and being adaptable for receiving a catheter shaft, the first therapeutic agent delivery conduit and the second therapeutic agent delivery conduit being separated from each other, and moveable independent of each other between the distal tip and the proximal base;
the first therapeutic agent delivery conduit including a first therapeutic agent delivery lumen and including a first therapeutic agent delivery port in communication with the first therapeutic agent delivery lumen;
the second therapeutic agent delivery conduit including a second therapeutic agent delivery lumen and including a second therapeutic agent delivery port in communication with the second therapeutic agent delivery lumen;
each therapeutic agent delivery conduit positioned at a radial distance from the longitudinal axis when each therapeutic agent delivery conduit is in a low-profile configuration when the longitudinal distance of the distal tip and the proximal base is at a maximum distance; and
each therapeutic agent delivery conduit resiliently bending between the low-profile configuration and an expanded configuration upon longitudinal translation of the distal tip toward the proximal base along the longitudinal axis, the radial distance from the longitudinal axis of each therapeutic agent delivery conduit increasing upon bending each therapeutic agent delivery conduit from the low-profile configuration to the expanded configuration.

### Claim 16 (depends on 15)

The device of claim 15, wherein each therapeutic agent delivery conduit further comprises a plurality of therapeutic agent delivery ports disposed along the therapeutic agent delivery conduit, each of the plurality of therapeutic agent delivery ports including a distal therapeutic agent delivery port located distally to a proximal therapeutic agent delivery port, the distal therapeutic agent delivery port having a larger cross-sectional area than the proximal therapeutic agent delivery port.

### Claim 17 (depends on 15)

The device of claim 15, wherein the device further comprises a catheter shaft extending in the proximal direction from the proximal base, the catheter shaft defining a third therapeutic agent delivery lumen in communication with the first therapeutic agent delivery lumen.

### Claim 18 (depends on 17)

The device of claim 17, wherein the third therapeutic agent delivery lumen is in further communication with the second therapeutic agent delivery lumen.

### Claim 19 (depends on 15)

The device of claim 15, wherein the device further comprises a catheter shaft comprising an expandable portion positioned between the proximal base and the distal tip, the expandable portion being inflatable between a deflated configuration and an inflated configuration, the catheter shaft extending from a proximal end along the longitudinal axis to a distal end positioned between the distal tip and the expandable portion; the catheter shaft contacting the proximal base between the expandable portion and the proximal end; the catheter shaft including an inflation lumen in communication with the expandable portion and extending from the proximal end to the expandable portion.

### Claim 20

A method of delivering a therapeutic agent to an interior wall of a body vessel at or near a treatment site, the method comprising:
(a) inserting a therapeutic agent delivery system into a body vessel, the therapeutic agent delivery system comprising
(i) a catheter shaft having an expandable portion being inflatable between a deflated configuration and an inflated configuration, the catheter shaft extending along a longitudinal axis from a proximal end to a distal end and including an inflation lumen in communication with the expandable portion; and
(ii) a therapeutic agent delivery conduit including a therapeutic agent delivery lumen and a therapeutic agent delivery port in communication with the therapeutic agent delivery lumen; the therapeutic agent delivery conduit being positioned external to the expandable portion of the catheter shaft and contacting at least a portion of an external surface of the expandable portion in the inflated configuration, and the therapeutic agent delivery conduit being moveable independent of the expandable portion in the deflated configuration;
(b) positioning a portion of the therapeutic agent delivery conduit proximate the treatment site, said therapeutica agent delvery conduit portion contacting the external surface of the expandable portion in the inflated configuration and having the therapeutic agent delivery port;
(c) inflating the expandable portion of the catheter shaft until at least the portion of the external surface of the expandable portion contacts the therapeutic agent delivery conduit;
(d) increasing the pressure of the expandable portion of the catheter shaft until the therapeutic agent delivery conduit is pressed into a wall of the body vessel;
(e) injecting a therapeutic agent into the therapeutic agent delivery lumen of the therapeutic agent delivery conduit to release the therapeutic agent through the therapeutic agent delivery port to the wall of the body vessel proximate the treatment site;
(f) deflating the expandable portion of the catheter shaft; and
(g) removing the therapeutic agent delivery system from the body vessel.
